Matches in Wikidata for { <http://www.wikidata.org/entity/Q82405020> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q82405020 description "article scientifique publié en 2009" @default.
- Q82405020 description "artículu científicu espublizáu n'avientu de 2009" @default.
- Q82405020 description "im Dezember 2009 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82405020 description "scientific article published on 27 December 2009" @default.
- Q82405020 description "wetenschappelijk artikel" @default.
- Q82405020 description "наукова стаття, опублікована в грудні 2009" @default.
- Q82405020 name "Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study" @default.
- Q82405020 name "Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study" @default.
- Q82405020 type Item @default.
- Q82405020 label "Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study" @default.
- Q82405020 label "Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study" @default.
- Q82405020 prefLabel "Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study" @default.
- Q82405020 prefLabel "Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study" @default.
- Q82405020 P1433 Q82405020-1181C278-F149-4C63-AD0E-E7EC81A5C248 @default.
- Q82405020 P1476 Q82405020-A4878A38-9B1D-4D1F-8C5B-E4EBF4F34FA7 @default.
- Q82405020 P2093 Q82405020-1B644FC0-6D96-4CE4-9296-9300C95E857E @default.
- Q82405020 P2093 Q82405020-2184B140-9F4F-4171-8F29-44CA36858FC1 @default.
- Q82405020 P2093 Q82405020-4E0CFD1A-AE1F-465E-9E76-53140DB987DB @default.
- Q82405020 P2093 Q82405020-BACE1C5A-3803-4E3F-9955-58BB3FB8CDED @default.
- Q82405020 P304 Q82405020-83AC9728-4513-4DA5-BFA3-D9FC50A64246 @default.
- Q82405020 P31 Q82405020-22A57133-D8F6-43E4-B23F-B9F2128110E4 @default.
- Q82405020 P356 Q82405020-2E0B4100-01D0-4259-9CAF-66D10AE22D67 @default.
- Q82405020 P433 Q82405020-D42E758C-6402-4280-A124-F8015FFF0289 @default.
- Q82405020 P478 Q82405020-6B5CEB50-7ABA-4823-ACA9-865C61C8FEDF @default.
- Q82405020 P50 Q82405020-41BC7234-17A2-47D2-902D-FCBD7FFD036A @default.
- Q82405020 P50 Q82405020-4C7E9FE1-3508-4737-9920-7B307ECA83F8 @default.
- Q82405020 P50 Q82405020-E37BAECB-EB9D-44A5-9438-3926A94B387C @default.
- Q82405020 P577 Q82405020-C0337368-219D-45D0-9363-382503C34FE8 @default.
- Q82405020 P698 Q82405020-8C217154-F92C-426A-9CCC-ECC39C23A8D5 @default.
- Q82405020 P921 Q82405020-150C19C1-8D4F-4DA3-802D-88637EABF09A @default.
- Q82405020 P356 J.1468-1331.2009.02890.X @default.
- Q82405020 P698 20050906 @default.
- Q82405020 P1433 Q15757256 @default.
- Q82405020 P1476 "Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study" @default.
- Q82405020 P2093 "A Garcia-Martinez" @default.
- Q82405020 P2093 "M Bartolome" @default.
- Q82405020 P2093 "R Arroyo" @default.
- Q82405020 P2093 "V de las Heras" @default.
- Q82405020 P304 "470-478" @default.
- Q82405020 P31 Q13442814 @default.
- Q82405020 P356 "10.1111/J.1468-1331.2009.02890.X" @default.
- Q82405020 P433 "3" @default.
- Q82405020 P478 "17" @default.
- Q82405020 P50 Q56991250 @default.
- Q82405020 P50 Q56991277 @default.
- Q82405020 P50 Q80427527 @default.
- Q82405020 P577 "2009-12-27T00:00:00Z" @default.
- Q82405020 P698 "20050906" @default.
- Q82405020 P921 Q461809 @default.